Loading...
NPI 1487657862 · Alamogordo, NM · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Fillmore Eye Clinic Incorporated is a ambulatory surgical clinic/center provider located in Alamogordo, New Mexico. This profile covers 14 Medicare and 10 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Fillmore Eye Clinic Incorporated |
| Address | 1124 10th St |
| City | Alamogordo |
| State | NM |
| ZIP | 88310 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | May 31, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.6M |
| Medicaid | $1.3M |
FILLMORE EYE CLINIC INCORPORATED operates as an Ambulatory Surgical Clinic/Center with meaningful activity in both surgical cataract services and office-based ophthalmic injections, as reflected by the code mix and reported revenues. The practice reported $2.6M in lifetime Medicare revenue and $1.3M in lifetime Medicaid revenue, indicating a substantive scale across both public payers while remaining largest on Medicare dollar terms.
Medicare revenue is concentrated in a small set of procedures: the top three Medicare codes (J2777, 66984, J1096) account for 66.1% of this provider’s Medicare revenue. Specifically, J2777 is $706.4K (26.1%), 66984 is $694.8K (25.7%), and J1096 is $386.5K (14.3%), showing dependence on intravitreal pharmaceuticals and cataract extraction with IOL placement for the majority of Medicare dollars.
Medicaid revenue is extremely concentrated: the top three Medicaid codes account for 99.3% of Medicaid revenue, and 66984 alone represents $1.2M (95.6%) of the provider’s $1.3M Medicaid total. This indicates that Medicaid dollars to the clinic are overwhelmingly driven by cataract extraction with IOL insertion, creating high downside sensitivity to changes in that single service’s utilization or reimbursement.
On Medicare competitive standing, the provider shows mixed positioning by code: J1096 ranks #18 of 282 providers nationally (94th percentile) and is described as notably above typical national volume, identifying the clinic as a national high-volume user of that ophthalmic insert. In contrast, J2777 (rank #408/2039, 80th percentile) and 66984 (rank #2112/15965, 87th percentile) are characterized as typical, unremarkable volumes nationally, indicating the clinic is not a dominant national cataract or faricimab provider despite high absolute dollars from those codes.
Within the state Medicaid market, 66984 ranks #5 of 26 in-state (84th percentile) and is characterized as typical, unremarkable volume for that code at the state level despite its dominant share of this clinic’s Medicaid revenue. Several Medicaid codes (J1096 at #1 of 1, J2403 at #1 of 2) have extremely small peer sets or no state peer comparison available, so apparent top-in-state positioning should be interpreted cautiously given limited in-state sample size.
The procedural mix and claim counts point to dual operational lines: high-volume intravitreal therapy throughput plus substantial cataract surgical capacity. Medicare claim counts show large injection volumes (J2777 24.4K claims; J1096 3.9K claims; other intravitreal agents appear in the top-25 list), while cataract procedure counts support a busy ambulatory surgical practice (Medicare 66984 884 claims; Medicaid 66984 2.6K claims).
The provider’s NPI was enumerated on 2005-05-31 (~21 years ago), indicating an established presence in the market. That tenure, combined with concentrated revenue streams (top 3 Medicare codes = 66.1%; top 3 Medicaid codes = 99.3%), suggests operational stability but also exposure if utilization or reimbursement for a small number of high-value codes changes.
Given the high Medicaid concentration in one service line (66984 at 95.6% of Medicaid revenue) and substantial Medicare reliance on a few ophthalmic drugs and procedures, payers should expect that shifts in drug pricing, coverage policies for ophthalmic inserts/injections, or cataract reimbursement could materially affect the clinic’s public-payer revenue mix. Monitoring utilization trends for J2777, 66984, and J1096 will capture most of this provider’s public-payer activity.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
14 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 24,360 | $30 | $706.4K |
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 880 | $790 | $694.8K |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | 3,900 | $100 | $386.5K |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 273,600 | $1 | $273.6K |
| J0178 | Injection, aflibercept, 1 mg | 360 | $690 | $246.3K |
| 66982 | The provider inserts an intraocular lens prosthesis after extracapsular cataract extraction using complex techniques and devices. He may perform this by means of an iris expansion device, providing… | 110 | $790 | $88.9K |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 650 | $120 | $77.4K |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 290 | $250 | $70.6K |
| 66991 | The provider inserts an intraocular lens prosthesis during the same session as extracapsular cataract extraction. The provider also inserts one or more anterior segment aqueous drainage devices in… | 20 | $2,370 | $56.8K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 220 | $180 | $38.1K |
Showing 1–10 of 14
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
14 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 12 | 20 | 1,100 | $690 | $816.1K |
| J2777 | 6 | 20 | 17,340 | $30 | $653.4K |
| J1096 | 1 | 10 | 2,390 | $100 | $236.9K |
| 66984 | 4 | 60 | 130 | $500 | $167.1K |
| J2403 | 1 | 10 | 273,600 | $1 | $152.7K |
| J0179 | 2 | 10 | 340 | $250 | $84.1K |
| 67028 | 10 | 30 | 390 | $90 | $71.6K |
| J2781 | 1 | 10 | 560 | $120 | $62K |
| 66991 | 3 | 10 | 20 | $1,850 | $48K |
| 66982 | 3 | 30 | 40 | $660 | $31.1K |
Showing 1–10 of 14
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 2,610 | $470 | $1.2M |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | 680 | $50 | $35.6K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 420 | $30 | $11.2K |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 110 | $60 | $6.6K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 90 | $20 | $2.1K |
| 68841 | The provider inserts an implant that delivers a drug at a controlled rate into the lacrimal ducts of the eye to treat inflammation, glaucoma, or other conditions. The provider may also dilate the… | 400 | $1 | $400 |
| 0356T | N/A | 140 | $1 | $280 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 30 | $0 | $0 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 30 | $0 | $0 |
| V2632 | Posterior chamber intraocular lens | 50 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other New Mexico providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Mexico median
10 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 5 | 30 | 280 | $400 | $607.8K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 8 | 10 | 1,470 | $70 | $340.1K |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | 1 | 10 | 680 | $50 | $35.3K |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 1 | 10 | 60 | $100 | $6.4K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 1 | 10 | 90 | $20 | $2.1K |
| 0356T | N/A | 2 | 10 | 150 | $10 | $950 |
| 68841 | The provider inserts an implant that delivers a drug at a controlled rate into the lacrimal ducts of the eye to treat inflammation, glaucoma, or other conditions. The provider may also dilate the… | 2 | 10 | 480 | $1 | $790 |
| V2632 | Posterior chamber intraocular lens | 6 | 10 | 130 | $1 | $210 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 10 | 10 | 210 | $1 | $40 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 7 | 10 | 560 | $0 | $0 |
Other providers in the same ZIP code as Fillmore Eye Clinic Incorporated, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.